Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes

The EMBO Reports(2009)10.1038/embor.2009.88Source: DataRank Database

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes is a research paper published in The EMBO Reports (2009). On theSindex it has a DataRank of 4.6. It has been cited 131 times, with 94 citing works in its 1-hop citation network.

N/A

4.6DataRank · unranked

Scored on demand from live citation data

131 citations · 94 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 4.28)OA: bronzeTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 16%Citation Network 84%

Base Score Contribution

0.732

From this paper's citation signal

Citation Network Contribution

3.9

From 88 citing papers with measurable signal

Learn more about DataRank methodology →

Authors (13)

Fabio Manzo,Marco Miceli,Mariarosaria Conte,Lucrezia Manente,Alfonso Baldi

Live enrichment

PubMed:19498465 PMC:PMC2693879 OpenAlex:https://openalex.org/W2110385915

FWCI

4.28

Citation Percentile

1.0%

Citation Trend

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

bronzeLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/embor.2009.88

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/embor.2009.88

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fembor.2009.88

publisherhttps://link.springer.com/content/pdf/10.1038/embor.2009.88.pdf

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1038/embor.2009.88

Fields of Study

Histone Deacetylase Inhibitors ResearchPeptidase Inhibition and AnalysisProtein Degradation and Inhibitors

MeSH Terms

AnimalsEnzyme InhibitorsHistone DeacetylasesHumansModels, BiologicalOrgan SpecificityRepressor ProteinsSubstrate SpecificityTranscription, GeneticMyogenic Regulatory FactorsMuscle DevelopmentCell Line, TumorMiceProtein StabilityHistone Deacetylase InhibitorsMEF2 Transcription Factors

Keywords

HDAC4Mef2Histone deacetylase 5Histone deacetylaseMyogenesisHDAC3Histone deacetylase 2HDAC11HDAC1HDAC6In vivoAcetylationBiologyHistoneSkeletal muscleMyocyteCell biologyBiochemistryChemistryEnhancerTranscription factorGeneticsEndocrinology

Sustainable Development Goals

SDG 0: Good health and well-being